Humana Inc. is in advanced talks to acquire Florida’s MaxHealth, valuing the primary care clinic operator at approximately $1 billion, per sources familiar with the discussions. The potential deal would expand Humana’s footprint in the healthcare sector, particularly in Florida, where MaxHealth manages a network of clinics focused on preventive care and chronic disease management. If finalized, the acquisition would mark a strategic move by Humana to strengthen its primary care offerings and compete more aggressively with rivals like UnitedHealth Group and CVS Health, which have also invested heavily in clinic-based services.

MaxHealth, which operates over 100 clinics across Florida, has built a reputation for integrating technology into patient care, including telehealth platforms and data-driven treatment plans. Humana’s interest aligns with its broader push to transition from traditional insurance models to value-based care, where providers are incentivized for patient outcomes rather than service volume. The deal, if completed, would add roughly 150,000 patients to Humana’s existing network, enhancing its ability to manage costs and improve health outcomes for members.

The proposed valuation highlights the premium healthcare buyers are willing to pay for established primary care infrastructure, especially in high-growth states like Florida. While details remain fluid, the move underscores intensifying consolidation in the U.S. healthcare market, driven by private equity firms and insurers seeking to control care delivery. Regulatory hurdles, however, could complicate the transaction, as antitrust reviews often scrutinize large-scale healthcare mergers.

This development signals Humana’s aggressive strategy to diversify revenue streams beyond insurance premiums. By acquiring MaxHealth, the company aims to position itself as a one-stop solution for patients, combining coverage with hands-on care. Analysts note that such vertical integration could improve Humana’s competitive edge but may also raise concerns about market dominance in Florida’s healthcare ecosystem.